Which of the following is true about Libman sacks endocarditis –
## **Core Concept**
Libman-Sacks endocarditis is a form of non-bacterial endocarditis associated with **Systemic Lupus Erythematosus (SLE)** and **Antiphospholipid Syndrome (APS)**. It involves the formation of sterile vegetations on heart valves, primarily affecting the mitral and tricuspid valves.
## **Why the Correct Answer is Right**
The correct answer involves understanding the characteristics of Libman-Sacks endocarditis. This condition is known for its association with SLE and APS, and it presents with sterile vegetations that can occur on either side of the valve leaflets. The vegetations in Libman-Sacks endocarditis are typically **less likely to embolize** compared to infective endocarditis, but they can cause valve dysfunction.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option might suggest a common cause or characteristic not specifically associated with Libman-Sacks endocarditis, such as a high likelihood of embolization similar to infective endocarditis, which is not accurate.
- **Option B:** If this option suggests a specific valve involvement not characteristic of Libman-Sacks endocarditis, such as exclusively affecting the aortic valve, it would be incorrect because Libman-Sacks endocarditis commonly affects the mitral and tricuspid valves.
- **Option C:** If this option provides a misleading association or characteristic, such as implying it is a bacterial form of endocarditis, it would be incorrect because Libman-Sacks endocarditis is a form of non-bacterial (or aseptic) endocarditis.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that Libman-Sacks endocarditis is a **complication of SLE and APS**, and its management involves treating the underlying disease process along with addressing any valve dysfunction. This condition highlights the importance of considering systemic diseases in patients presenting with cardiac symptoms.
## **Correct Answer:** C. Libman-Sacks endocarditis is associated with SLE and Antiphospholipid syndrome.